The Role of the FDA in Allowing Chemicals into America's Food

Joseph Shea, a resident of Myrtle Beach, South Carolina, who makes a living selling sportswear, often ponders the safety of the food available to him.

Mystery ingredients with complex names, vague mentions of natural or artificial flavors, and the allure of affordable junk food that feels addictive and health-compromising are his concerns.

Shea participated in a KFF survey addressing health care priorities, expressing a common assumption that the FDA assures ingredient safety.

However, that's not always the reality.

Limited Oversight by the FDA

Investigations by KFF Health News reveal that the FDA's regulatory power over food ingredients is weak and limited. Contrary to the presumption of many, about 950 substances prohibited in Europe are used in U.S. foods.

The new Health and Human Services Secretary has long been critical of food additives, seeking to overhaul policies. During confirmation hearings, Trump-nominated FDA head, Martin Makary, flagged ingredients not naturally occurring as concerns.

Industry often deems chemicals safe, yet oversight remains minimal. Efforts to cut FDA staff under the Trump administration led to the food safety director Jim Jones stepping down, raising alarms about potential reduced scrutiny.

Self-Policing in Food Safety

The FDA largely empowers food manufacturers to self-determine ingredient safety. Companies are not mandated to disclose decisions or list all ingredients on labels.

In contrast to drug makers, food companies need not submit comprehensive human research data to the FDA.

Ex-FDA commissioner Robert Califf noted to a Senate committee that the agency lacks access to significant industry research.

The Secretive Ingredient List

Major food manufacturers like Coca-Cola, Conagra, and Unilever were queried about undisclosed ingredients safe without FDA input and those varying between the U.S. and European markets. Answers were not forthcoming.

Despite claims to quality compliance, questionable chemicals such as titanium dioxide and potassium bromate are permitted stateside but restricted elsewhere.

Regulatory Limitations and Consumer Denial

The Reagan-Udall Foundation points out potential dangers in unnamed ingredients due to legal fears, while common labeling terms hide others behind legal shields.

Ultra-processed foods dominate the U.S. market, making up about 73% and contributing to dietary health issues. Senator Bernie Sanders connects them to obesity, highlighting shared concerns across political lines.

Makary voiced apprehensions about ingredients causing gastrointestinal inflammation. A poll indicated that most Americans support strict controls on food chemicals.

Additives Banned Elsewhere

Certain additives, frowned upon in Europe, persist in the U.S. The European Union's 2021 stance on titanium dioxide's carcinogenic risks contrasts with its continued use in American products.

Potassium bromate, long labeled a carcinogen, is another additive outlawed in many countries yet still present in U.S. foods.

A System Overdependence on GRAS

The 1958 Food Additives Amendment required manufacturers to justify safety for additive use, but GRAS—Originally meant for common substances like salt—has allowed a loophole for many chemicals.

Today, manufacturers often independently conclude safety without FDA intervention, leaving regulatory gaps exacerbated by industry-panel reviews sometimes colored by financial interests.

Case Studies and Industry Practices

Companies might inform the FDA of their GRAS determinations with little oversight, allowing almost immediate market access.

The agency rarely rejects such claims, often pausing reviews at the company’s behest, retaining the firm’s freedom to market.

Consequences and Individual Concerns

Psyched Wellness' recent GRAS-based market entry illustrates the risks, as FDA concerns later arose, including known issues with neurotoxicity.

With long-term health effects potentially obscured, consumers like Joseph Shea continue to voice frustration at food ingredient transparency challenges and their potential risks.